chartexchange

ENDV
NDONOVO THERAPEUTICS INC
stockOTC

EODNov 18, 2026
0.0001USD0.000%(0.00)200,000
Loading…
Loading…
Healthcare
Biotechnology
HQ
Woodland Hills, CA, USA
Previous Close
$0.00
Beta
-70.63
52-Week High
$0.00 2025-12-01
52-Week Low
$0.00 2026-11-10
SMA 50
$0.00
SMA 200
$0.00
Avg. Vol 10D
639,270
Avg. Vol 30D
562,216
Avg. Vol 90D
1.00M
Relative Vol
0.36
396.83M
240.02M
10,000
Dec 20, 2019 · 1-for-1000 (reverse)
ENDV Profile

endonovo therapeutics (otcqb: endv) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. endonovo's immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation and necrosis, and the promotion of regeneration. endonovo's cytotronics™ platform provides for a method of expanding and manipulating cells using simulated microgravity and time-varying electromagnetic fields (tvemf) for tissue engineering and cell therapies.

ENDV Performance
PeriodPriceDateChangeBeta
1W0.002026-11-10+9900.00%-13961.235
6M0.002026-05-26+9900.00%-44.832
2Y0.002024-11-19-88.89%—
5Y0.022021-11-19-99.42%-7.271
ENDV Stock Summary

NDONOVO THERAPEUTICS INC (OTC:ENDV) stock price today is $0.00, and today's volume is 200,000. ENDV is up 0.000% today. The 30 day average volume is 562,216. ENDV market cap is $39,683 with 396.83M shares outstanding.